Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-26 @ 8:25 PM
Study NCT ID:
NCT00069992
Status:
TERMINATED
Last Update Posted:
2012-10-10
First Post:
2003-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
Sponsor:
Baylor College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-12
Start Date Type:
None
Primary Completion Date:
2006-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-04
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-03
First Submit QC Date:
None
Study First Post Date:
2003-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-10-05
Last Update Post Date:
2012-10-10
Last Update Post Date Type:
ESTIMATED